Role of LRP1 and ERK and cAMP Signaling pathways in lactoferrin-induced lipolysis in mature rat adipocytes

PLoS ONE

Volumn 10, Issue 10, 2015, Pages

  Ikoma Seki, Keiko ^a,b   Nakamura, Kanae ^a   Morishita, Satoru ^a   Ono, Tomoji ^a,b   Sugiyama, Keikichi ^a,d   Nishino, Hoyoku ^c,d   Hirano, Hisashi ^b   Murakoshi, Michiaki ^a,b,c  

^a LION CORPORATION   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

^c KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^d RITSUMEIKAN UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; HORMONE SENSITIVE LIPASE; LACTOFERRIN; LIPOPROTEIN RECEPTOR; LIPOPROTEIN RECEPTOR RELATED PROTEIN 1; MITOGEN ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; CHOLESTEROL ESTERASE; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL ASSAY; CELL MATURATION; CONTROLLED STUDY; ENZYME ACTIVATION; FUNCTIONAL PROTEOMICS; INTRACELLULAR SIGNALING; LIPOLYSIS; MALE; MESENTERIC FAT; NONHUMAN; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RAT; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; BOVINE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; INTRAABDOMINAL FAT; METABOLISM; PROTEOMICS; SIGNAL TRANSDUCTION;

ADIPOCYTES; ANIMALS; CATTLE; CYCLIC AMP; GENE EXPRESSION REGULATION; INTRA-ABDOMINAL FAT; LACTOFERRIN; LIPOLYSIS; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-1; MAP KINASE SIGNALING SYSTEM; PROTEOMICS; RATS; STEROL ESTERASE;

EID: 84949575479     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0141378     Document Type: Article

References (56)

1. Mota M, Pànuş C, Mota E, Lichiardopol C, Vladu D, Toma E. The metabolic syndrome - amultifaced disease. Rom J Intern Med. 2004; 42(2):247-55 PMID: 15529615
2. Hashimoto N, Saito Y. [Diagnostic criteria of insulin resistance and multiple risk factor syndrome]. Nihon Rinsho. 2000 Feb; 58(2):405-10 PMID: 10707566
3. Duvnjak L, Duvnjak M. The metabolic syndrome - an ongoing story. J Physiol Pharmacol. 2009 Dec; 60 Suppl 7:19-24 PMID: 20388942
4. You T, Nicklas BJ, Ding J, Penninx B.W., Goodpaster BH, Bauer DC, et al. The metabolic syndrome is associated with circulating adipokines in older adults across a wide range of adiposity. J Gerontol A Biol Sci Med Sci. 2008 Apr; 63(4):414-9 PMID: 18426966
5. Abete I, Goyenechea E, Zulet M.A., Martínez JA. Obesity and metabolic syndrome: potential benefit from specific nutritional components. Nutr Metab Cardiovasc Dis. 2011 Sep; 21 Suppl 2:B1-15 doi: 10.1016/j.numecd.2011.05.001 PMID: 21764273
6. Harmsen MC, Swart PJ, de Béthune MP, Pauwels R, DeClercq E, The TH, et al. Antiviral effects of plasma and milk proteins: lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro. J Infect Dis. 1995 Aug; 172(2):380-8 PMID: 7622881
7. Sekine K, Ushida Y, Kuhara T, Iigo M, Baba-Toriyama H, Moore MA, et al. Inhibition of initiation and early stage development of aberrant crypt foci and enhanced natural killer activity in male rats administered bovine lactoferrin concomitantly with azoxymethane. Cancer Lett. 1997 Dec; 121(2):211-6 PMID: 9570361
8. Shoji H, Oguchi S, Shinohara K., Shimizu T, Yamashiro Y. Effects of iron-unsaturated human lactoferrin on hydrogen peroxide-induced oxidative damage in intestinal epithelial cells. Pediatr Res. 2007 Jan; 61 (1):89-92 PMID: 17211147
9. Tomita M, Bellamy W, Takase M., Yamauchi K, Wakabayashi H, Kawase K. Potent antibacterial peptides generated by pepsin digestion of bovine lactoferrin. J Dairy Sci. 1991 Dec; 74(12):4137-42 PMID: 1787185
10. Zimecki M, Wtaszczyk A, Cheneau P., Brunel AS, Mazurier J, Spik G, et al. Immunoregulatory effects of a nutritional preparation containing bovine lactoferrin taken orally by healthy individuals. Arch Immunol Ther Exp (Warsz). 1998; 46(4):231-40
11. Ono T, Morishita S, Fujisaki C, Ohdera M, Murakoshi M, Iida N, et al. Effects of pepsin and trypsin on the anti-adipogenic action of lactoferrin against pre-adipocytes derived from rat mesenteric fat. Br J Nutr. 2011 Jan; 105(2):200-11 doi: 10.1017/S0007114510003259 PMID: 20854698
12. Ono T, Murakoshi M, Suzuki N, Iida N, Ohdera M, Iigo M, et al. Potent anti-obesity effect of entericcoated lactoferrin: decrease in visceral fat accumulation in Japanese men and women with abdominal obesity after 8-week administration of enteric-coated lactoferrin tablets. Br J Nutr. 2010 Dec; 104 (11):1688-95 doi: 10.1017/S0007114510002734 PMID: 20691130
13. Morishita S, Ono T, Fujisaki C, Ishihara Y, Murakoshi M, Kato H, et al. Bovine lactoferrin reduces visceral fat and liver triglycerides in ICRmice. J Oleo Sci. 2013; 62(2):97-103 PMID: 23391533
14. Yagi M, Suzuki N, Takayama T, Arisue M, Kodama T, Yoda Y, et al. Lactoferrin suppress the adipogenic differentiation of MC3T3-G2/PA6 cells. J Oral Sci. 2008 Dec; 50(4):419-25 PMID: 19106469
15. Moreno-Navarrete J.M., Ortega FJ, Ricart W, Fernandez-Real JM. Lactoferrin increases (172Thr)AMPK phosphorylation and insulin-induced (p473Ser)AKT while impairing adipocyte differentiation. Int J Obes (Lond). 2009 Sep; 33(9):991-1000
16. Shi J, Finckenberg P, Martonen E., Ahlroos-Lehmus A, Pilvi TK, Korpela R, et al Metabolic effects of lactoferrin during energy restriction and weight regain in diet-induced obese mice. J Funct Foods. 2012 Jan; 4(1):66-78
17. Adams JP, Roberson ED, English J.D., Selcher JC, Sweatt JD. MAPK regulation of gene expression in the central nervous system. Acta Neurobiol Exp (Wars). 2000; 60(3):377-94
18. Rappsilber J, Ishihama Y, Mann M. Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics. Anal Chem. 2003 Feb; 75 (3):663-70 PMID: 12585499
19. Umekawa T, Yoshida T, Sakane N, Kogure A., Kondo M, Honjyo H. Trp64Arg mutation of beta3-adrenoceptor gene deteriorates lipolysis induced by beta3-adrenoceptor agonist in human omental adipocytes. Diabetes. 1999 Jan; 48(1):117-20 PMID: 9892231
20. Souza SC, Muliro KV, Liscum L, Lien P, Yamamoto MT, Schaffer JE, et al. Modulation of hormone-sensitive lipase and protein kinase A-mediated lipolysis by perilipin A in an adenoviral reconstituted system. J Biol Chem. 2002 Mar; 277(10):8267-72 PMID: 11751901
21. Su CL, Sztalryd C, Contreras JA, Holm C, Kimmel AR, Londos C. Mutational analysis of the hormonesensitive lipase translocation reaction in adipocytes. J Biol Chem. 2003 Oct; 278(44):43615-9 PMID: 12832420
22. Sztalryd C, Xu G, Dorward H, Tansey JT, Contreras JA, Kimmel AR, et al. Perilipin A is essential for the translocation of hormone-sensitive lipase during lipolytic activation. J Cell Biol. 2003 Jun; 161(6):1093-103 PMID: 12810697
23. Tian JH, Wang XM, Han JS. [Transcriptional regulation by CREB and proteins of CREB family]. Sheng Li KeXue Jin Zhan. 1996 Jul; 27(3):227-32 PMID: 9772361
24. Yamamoto KK, Gonzalez GA, Biggs W.H., Montminy MR. Phosphorylation-induced binding and transcriptional efficacy of nuclear factor CREB. Nature. 1988 Aug; 334 (6182):494-8 PMID: 2900470
25. Gonzalez GA, Montminy MR Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell. 1989 Nov; 59(4):675-80 PMID: 2573431
26. Lampidonis AD, Stravopodis DJ, Voutsinas G.E., Messini-Nikolaki N, Stefos GC, Margaritis L.H., et al. Cloning and functional characterization of the 5' regulatory region of ovine Hormone Sensitive Lipase (HSL) gene. Gene. 2008 Dec; 427(1-2):65-79 PMID: 18824087
27. Cooper DM, Crossthwaite AJ Higher-order organization and regulation of adenylyl cyclases. Trends Pharmacol Sci. 2006 Aug; 27(8):426-31 PMID: 16820220
28. Chao JR, Ni YG, Bolaños CA, Rahman Z., DiLeone RJ, Nestler EJ. Characterization of the mouse adenylyl cyclase type VIII gene promoter: regulation byc AMP and CREB. Eur J Neurosci. 2002 Oct; 16 (7):1284-94 PMID: 12405989
29. Gao MH, Tang T, Guo T, Sun SQ, Feramisco JR, Hammond HK. Adenylyl cyclase type VI gene transfer reduces phospholamban expression in cardiac myocytes via activating transcription factor 3. J Biol Chem. 2004 Sep; 279(37):38797-802 PMID: 15231818
30. Suzuki YA, Lopez V, Lönnerdal B. Mammalian lactoferrin receptors: structure and function. Cell Mol Life Sci. 2005 Nov; 62(22):2560-75 PMID: 16261254
31. Herz J, Strickland DK LRP: a multifunctional scavenger and signaling receptor. J Clin Invest. 2001 Sep; 108(6):779-84 PMID: 11560943
32. Goretzki L, Mueller BM Low-density-lipoprotein-receptor-related protein (LRP) interacts with a GTP-binding protein. Biochem J. 1998 Dec; 336 (Pt 2):381-6 PMID: 9820815
33. Frühbeck G., Méndez-Giménez L, Fernández-Formoso JA, Fernández S, Rodríguez A. Regulation of adipocyte lipolysis. Nutr Res Rev. 2014 Jun; 27(1):63-93 doi: 10.1017/S095442241400002X PMID: 24872083
34. Lafontan M, Langin D. Lipolysis and lipid mobilization in human adipose tissue. Prog Lipid Res. 2009 Sep; 48(5):275-97 doi: 10.1016/j.plipres.2009.05.001 PMID: 19464318
35. Roskoski R. ERK1/2 MAP kinases: structure, function, and regulation. Pharmacol Res. 2012 Aug; 66 (2):105-43 doi: 10.1016/j.phrs.2012.04.005 PMID: 22569528
36. Takayama Y, Takahashi H, Mizumachi K, Takezawa T. Low density lipoprotein receptor-related protein (LRP) is required for lactoferrin-enhanced collagen gel contractile activity of human fibroblasts. J Biol Chem. 2003 Jun; 278(24):22112-8 PMID: 12672816
37. Grey A, Banovic T, Zhu Q, Watson M, Callon K, Palmano K, et al. The low-density lipoprotein receptorrelated protein 1 is a mitogenic receptor for lactoferrin in osteoblastic cells. Mol Endocrinol. 2004 Sep; 18(9):2268-78 PMID: 15178744
38. Tang L, Wu JJ, Ma Q, Cui T., Andreopoulos FM, Gil J, et al. Human lactoferrin stimulates skin keratinocyte function and wound re-epithelialization. BrJ Dermatol. 2010 Jul; 163(1):38-47 doi: 10.1111/j.1365-2133.2010.09748.x PMID: 20222924
39. Xia Z, Storm DR Role of signal transduction crosstalk between adenylyl cyclase and MAP kinase in hippocampus-dependent memory. Learn Mem. 2012 Sep; 19(9):369-74 doi: 10.1101/lm.027128.112 PMID: 22904367
40. Bockaert J. [G-protein-coupled receptors: general features and activation mechanisms]. Bull Acad Natl Med. 2012 Dec; 196(9):1765-75 PMID: 24552100
41. Filardo EJ, Quinn JA, Frackelton A.R., Bland KI. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol Endocrinol. 2002 Jan; 16(1):70-84 PMID: 11773440
42. Dumaz N, Marais R. Integrating signals between cAMPandthe RAS/RAF/MEK/ERK signalling pathways. Based on the anniversary prize of the Gesellschaft für Biochemie und Molekularbiologie Lecture delivered on 5 July 2003 at the Special FEBS Meeting in Brussels. FEBS J. 2005 Jul; 272(14):3491-504 PMID: 16008550
43. Beazely MA, Alan JK, Watts VJ Protein kinase C and epidermal growth factor stimulation of Raf1 potentiates adenylyl cyclase type 6 activation in intact cells. Mol Pharmacol. 2005 Jan; 67(1):250-9 PMID: 15470083
44. Tan CM, Kelvin DJ, Litchfield D.W., Ferguson SS, Feldman RD. Tyrosine kinase-mediated serine phosphorylation of adenylyl cyclase. Biochemistry. 2001 Feb; 40(6):1702-9 PMID: 11327830
45. Uemura Y, Shibata R, Ohashi K, Enomoto T, Kambara T, Yamamoto T, et al. Adipose-derived factor CTRP9 attenuates vascular smooth muscle cell proliferation and neointimal formation. FASEB J. 2013 Jan; 27(1):25-33 doi: 10.1096/fj.12-213744 PMID: 22972916
46. Smit MJ, Verzijl D, Iyengar R. Identity of adenylyl cyclase isoform determines the rate of cell cycle progression in NIH 3T3 cells. Proc Natl Acad Sci USA. 1998 Dec; 95(25):15084-9 PMID: 9844019
47. Park HY, Kang YM, Kang Y, Park TS, Ryu YK, Hwang JH, et al. Inhibition of adenylyl cyclase type 5 prevents L-DOPA-induced dyskinesia in an animal model of Parkinson's disease. J Neurosci. 2014 Aug; 34(35):11744-53 doi: 10.1523/JNEUROSCI.0864-14.2014 PMID: 25164669
48. Ding Q, Gros R, Gray ID, Taussig R, Ferguson SS, Feldman RD. Raf kinase activation of adenylyl cyclases: isoform-selective regulation. Mol Pharmacol. 2004 Oct; 66(4):921-8 PMID: 15385642
49. Dumaz N, Marais R. Protein kinase A blocks Raf-1 activity by stimulating 14-3-3 binding and blocking Raf-1 interaction with Ras. J Biol Chem. 2003 Aug; 278(32):29819-23 PMID: 12801936
50. Rommel C, Clarke BA, Zimmermann S, Nuñez L, Rossman R., Reid K, et al. Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt. Science. 1999 Nov; 286 (5445):1738-41 PMID: 10576741
51. Feldman DS, Zamah AM, Pierce K.L., Miller WE, Kelly F, Rapacciuolo A, et al Selective inhibition of heterotrimeric Gs signaling. Targeting the receptor-G protein interface using a peptide minigene encoding the Galpha(s) carboxyl terminus. J Biol Chem. 2002 Aug; 277(32):28631-40 PMID: 12036966
52. Barnes H, Ackermann EJ, van der Geer P. v-Src induces Shc binding to tyrosine 63 in the cytoplasmic domain of the LDL receptor-related protein 1. Oncogene. 2003 Jun; 22(23):3589-97 PMID: 12789267
53. Barnes H, Larsen B, Tyers M., van Der Geer P. Tyrosine-phosphorylated low density lipoprotein receptor-related protein 1 (Lrp1) associates with the adaptor protein SHCin SRC-transformed cells. J Biol Chem. 2001 Jun; 276(22):19119-25 PMID: 11259429
54. Shi Y, Mantuano E, Inoue G, Campana WM, Gonias SL. Ligand binding to LRP1 transactivates Trk receptors by a Src family kinase-dependent pathway. Sci Signal. 2009; 2(68):ra18 doi: 10.1126/scisignal.2000188 PMID: 19401592
55. Loukinova E, Ranganathan S, Kuznetsov S., Gorlatova N, Migliorini MM, Loukinov D, et al Plateletderived growth factor (PDGF)-induced tyrosine phosphorylation of the low density lipoprotein receptorrelated protein (LRP). Evidence for integrated co-receptor function betwenn LRPandthe PDGF. J Biol Chem. 2002 May; 277(18):15499-506 PMID: 11854294
56. Dougherty MK, Müller J, Ritt D.A., Zhou M., Zhou XZ, Copeland TD, et al. Regulation of Raf-1 by direct feedback phosphorylation. Mol Cell. 2005 Jan; 17(2):215-24 PMID: 15664191